MedTrace Logo

Patient and Colonoscopy Cleansing Quality Agreement

NCT04702646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1011

Last updated 2022-09-21

No results posted yet for this study

Summary

The main purpose of the study is to determine the agreement between colon cleansing quality assessed by a validated scale (Boston Bowel Preparation Scale, BBPS) and the perception of the patient. Patients will be prepared with polyethylene glycol (PEG), PEG plus ascorbic acid (PEG-Asc) or sodium picosulfate-oxide magnesium solution (PS).

The secondary aim is to assess predictors of poor bowel cleansing.

Conditions

  • Cleansing Quality of the Colon

Interventions

DRUG

Bowel preparation before colonoscopy

one day liquid diet will be administered to every patient included in the study and: split-dose bowel preparation with 4 Liters of Polyethylene glycol solution, 2 Liters of PEG-Ascorbic acid or 2 Liters Picosulfate.

PROCEDURE

Colonoscopy

colonoscopy will be performed to every patient included in the study

Sponsors & Collaborators

  • Hospital Universitario de Canarias

    lead OTHER

Principal Investigators

  • Antonio Z Gimeno Garcia, MD, PhD · Hospital Universitario de Canarias

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2021-05-31
Completion
2021-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04702646 on ClinicalTrials.gov